Michiana Hematology Oncology PC-Niles
Niles, Michigan 49120
0 studies enrolling now · 24 studies all time
What they study most
Anal Cancer, Breast Adenocarcinoma, Breast Cancer, Carcinoma of the Appendix, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Chemotherapeutic Agent Toxicity, Chronic Myeloproliferative Disorders, Cognitive Side Effects of Cancer Therapy, Colorectal Cancer, DS Stage I Plasma Cell Myeloma
Studies at this site
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
- Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma — Stopped early
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Running, not enrolling
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy — Completed
- Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia — Stopped early
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases — Completed
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer — Completed
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer — Completed
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — Completed
- Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer — Completed
- Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer — Completed
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy — Completed
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
- Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer — Stopped early
- Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer — Completed
- Collection of Patient-Reported Symptoms and Performance Status Via the Internet — Completed
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer — Completed
- Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer — Stopped early
- Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer — Completed
- American Ginseng in Treating Patients With Fatigue Caused by Cancer — Completed
- Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy — Completed
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy — Stopped early